These findings were more recently mirrored by similar findings in a mouse model of human pancreatic adenocarcinoma (PDAC), where CtBP2 deficiency slowed tumor growth, abrogated metastases, and severely attenuated expression of TIC markers25. Here, CTBP2 is linked to neoplasm.